ARTIVION, INC. (AORT)
Data as of , from SEC Form 4 filings.
See up to 3 months of AORT. The 7-day demo opens the 1M and 3M ranges and puts AORT on your watchlist.
Start 7-day demoLatest AORT insider trades
About ARTIVION, INC. (AORT)
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
- KENNESAW, GA
- 1,800
- 1993
- XNYS
AORT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 91,791 | $2.60M |
AORT insider transactions (Form 4)
7367 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 2,423 footnote F1 | $37.59 | $91K | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 1,259 footnote F2 | $35.69 | $45K | |
| ||||||
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 3,079 footnote F1 | $37.59 | $116K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 1,668 footnote F2 | $35.69 | $60K | |
| Jean F. Holloway - Officer | Grant or award | Common Stock | 20,085 footnote F3 | $0.00 | - | |
| ||||||
| Open-market sale | Common Stock | 20,962 footnote F1 | $37.59 | $788K | ||
| Open-market sale | Common Stock | 13,936 footnote F2 | $35.69 | $497K | ||
| Grant or award | Common Stock | 97,030 footnote F3 | $0.00 | - | ||
| ||||||
| Lance A. Berry - Officer | Open-market sale | Common Stock | 4,981 footnote F1 | $37.59 | $187K | |
| Lance A. Berry - Officer | Open-market sale | Common Stock | 4,485 footnote F2 | $35.69 | $160K | |
| Lance A. Berry - Officer | Grant or award | Common Stock | 37,482 footnote F3 | $0.00 | - | |
| ||||||
| John E. Davis - Officer | Open-market sale | Common Stock | 3,773 footnote F1 | $37.59 | $142K | |
| John E. Davis - Officer | Open-market sale | Common Stock | 2,075 footnote F2 | $35.69 | $74K | |
| John E. Davis - Officer | Grant or award | Common Stock | 20,438 footnote F3 | $0.00 | - | |
| ||||||
| Option exercise | Common Stock | 30,921 footnote F1 | $29.62 | $916K | ||
| Open-market sale | Common Stock | 30,921 footnote F1 | $45.46 footnote F2 | $1.41M | ||
| Option exercise | Stock Options (Right to buy) | 30,921 | $0.00 | - | ||
| ||||||
| Option exercise | Common Stock | 30,921 footnote F1 | $29.62 | $916K | ||
| Open-market sale | Common Stock | 30,921 footnote F1 | $45.56 footnote F2 | $1.41M | ||
| Option exercise | Stock Options (Right to buy) | 30,921 | $0.00 | - | ||
| ||||||
| Gift | Common Stock | 750 footnote F1 | $0.00 | - | ||
| ||||||
| Marshall S. Stanton - Officer | Option exercise | Common Stock | 2,033 | $18.44 | $37K | |
| Marshall S. Stanton - Officer | Option exercise | Common Stock | 1,355 | $11.03 | $15K | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 11,888 | $44.14 footnote F1 | $525K | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 2,033 | $44.32 footnote F2 | $90K | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 1,355 | $44.28 footnote F3 | $60K | |
| Marshall S. Stanton - Officer | Option exercise | Stock Options (Right to buy) | 2,033 | $0.00 | - | |
| Marshall S. Stanton - Officer | Option exercise | Stock Options (Right to buy) | 1,355 | $0.00 | - | |
| ||||||
| Elizabeth A. Hoff - Director | Open-market sale | Common Stock | 4,200 | $45.10 footnote F1 | $189K | |
| ||||||
| Jean F. Holloway - Officer | Option exercise | Stock Options (Right to buy) | 6,394 footnote F1 | $0.00 | - | |
| Jean F. Holloway - Officer | Option exercise | Common Stock | 6,393 footnote F1 | $29.62 | $189K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 6,393 footnote F1 | $45.00 | $288K | |
| Jean F. Holloway - Officer | Option exercise | Common Stock | 6,394 footnote F1 | $29.62 | $189K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 6,394 footnote F1 | $45.17 | $289K | |
| Jean F. Holloway - Officer | Option exercise | Stock Options (Right to buy) | 6,393 footnote F1 | $0.00 | - | |
| ||||||
| John E. Davis - Officer | Open-market sale | Common Stock | 6,393 footnote F1 | $44.67 | $286K | |
| John E. Davis - Officer | Option exercise | Common Stock | 6,394 footnote F1 | $29.62 | $189K | |
| John E. Davis - Officer | Open-market sale | Common Stock | 6,394 footnote F1 | $45.17 | $289K | |
| John E. Davis - Officer | Option exercise | Stock Options (Right to buy) | 6,393 footnote F1 | $0.00 | - | |
| John E. Davis - Officer | Option exercise | Stock Options (Right to buy) | 6,394 footnote F1 | $0.00 | - | |
| John E. Davis - Officer | Option exercise | Common Stock | 6,393 footnote F1 | $29.62 | $189K | |
| ||||||
| Open-market sale | Common Stock | 6,000 | $45.73 footnote F1 | $274K | ||
| ||||||
| Open-market sale | Common Stock | 3,482 footnote F1 | $45.86 | $160K | ||
| ||||||
| John E. Davis - Officer | Open-market sale | Common Stock | 6,563 footnote F1 | $45.86 | $301K | |
| ||||||
| Open-market sale | Common Stock | 34,210 footnote F1 | $45.86 | $1.57M | ||
| ||||||
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 5,761 footnote F1 | $45.86 | $264K | |
| ||||||
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 4,993 footnote F1 | $45.86 | $229K | |
| ||||||
| Jean F. Holloway - Officer | Option exercise | Stock Options (Right to buy) | 10,000 | $0.00 | - | |
| Jean F. Holloway - Officer | Option exercise | Common Stock | 10,000 | $11.03 | $110K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 10,000 | $46.18 | $462K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 2,960 footnote F1 | $44.62 | $132K | |
| ||||||
| Open-market sale | Common Stock | 17,580 footnote F1 | $44.62 | $784K | ||
| ||||||
| John E. Davis - Officer | Open-market sale | Common Stock | 3,373 footnote F1 | $44.62 | $150K | |
| ||||||
| Open-market sale | Common Stock | 1,789 footnote F1 | $44.62 | $80K | ||
| ||||||
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 2,566 footnote F1 | $44.62 | $114K | |
| ||||||
| Marshall S. Stanton - Officer | Option exercise | Common Stock | 18,200 | $11.03 | $201K | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 18,200 | $44.02 | $801K | |
| Marshall S. Stanton - Officer | Option exercise | Stock Option (Right to Buy) | 18,200 | $0.00 | - | |
| Jean F. Holloway - Officer | Option exercise | Common Stock | 10,000 | $11.03 | $110K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 10,000 | $44.37 | $444K | |
| Jean F. Holloway - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Open-market sale | Common Stock | 12,500 | $42.32 | $529K | ||
| John E. Davis - Officer | Option exercise | Common Stock | 10,802 | $26.24 | $283K | |
| John E. Davis - Officer | Open-market sale | Common Stock | 10,802 | $43.67 | $472K | |
| John E. Davis - Officer | Option exercise | Stock Options (Right to buy) | 10,802 | $0.00 | - | |
| Jean F. Holloway - Officer | Option exercise | Common Stock | 16,975 | $26.24 | $445K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 16,975 | $43.01 | $730K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 6,381 | $43.02 | $274K | |
| Jean F. Holloway - Officer | Option exercise | Stock Option(Right to Buy) | 16,975 | $0.00 | - | |
| Option exercise | Common Stock | 7,992 | $29.62 | $237K | ||
| Open-market sale | Common Stock | 7,992 | $38.49 | $308K | ||
| Option exercise | Stock Option (Right to Buy) | 7,992 | $0.00 | - | ||
| Daniel J. Bevevino - Director | Grant or award | Common Stock | 6,325 | $0.00 | - | |
Recent AORT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| GREEN ANDREW M | Officer | 11,480 | $287K | View on EDGAR | |
| GREEN ANDREW M | Officer | 1,493 | $39K |
Stock trades in AORT disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Purchase |
AORT insider trading FAQ
What is the latest insider trade for AORT?
ARTIVION, INC. (AORT) had 6 insider filings in the last 90 days, with the most recent on 2026-09-11. The full record for AORT runs to 67 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AORT stock?
No insider purchases of AORT were filed in the last 90 days.
How many insiders are selling AORT stock?
7 insider sales of AORT were filed in the last 90 days, totaling $2.60M.
Where can I see AORT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AORT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Andrew M. Green view on EDGAR
- - Andrew M. Green view on EDGAR
- - James P. Mackin view on EDGAR
- - Andrew M. Green view on EDGAR
- - Lance A. Berry view on EDGAR
- - Jean F. Holloway view on EDGAR
- - Andrew M. Green view on EDGAR
- - Anthony B. Semedo view on EDGAR
- - Marna P. Borgstrom view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AORT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AORT with a 7-day demo
- AORT on your watchlist
- Every AORT Form 4 filing on record
- Up to 3 months of AORT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive